Methodology note
Guideline for the economic evaluation of medicines: a proposal by the Spanish National Health System's Advisory Committee for Pharmaceutical Financing
Guía para la evaluación económica de medicamentos: propuesta del Comité Asesor para la Financiación de la Prestación Farmacéutica del Sistema Nacional de Salud español
Marta Trapero-Bertrana,
, Juan Olivab,c, Ferrán Catalá-Lópezd,e,f, Lidia García-Pérezg,h, Lluís Segúi,j, Emilio Jesús Alegre-del-Reyk, Ana Clopésl, Félix Lobom, Ana Ortegan, Jaume Puig-Junoyo
Autor para correspondencia
a Department of Economics and Business, University of Lleida, Lleida, Spain
b Department of Economic Analysis and Research Seminar in Economics and Health (SIES), University of Castilla-La Mancha, Toledo, Spain
c Centre for Biomedical Research in Frailty and Healthy Ageing (CIBERFES), Spain
d Center for Human and Social Sciences (CCHS-IPP), Spanish National Research Council, Madrid, Spain
e Department of Health Planning and Economics, National School of Public Health, Institute of Health Carlos III, Madrid, Spain
f Centre for Biomedical Research in Mental Health Network (CIBERSAM), Spain
g Evaluation Service of the Canary Islands Health Service (SESCS), Tenerife, Spain
h Research Network on Chronic Conditions, Primary Care, and Health Promotion and Prevention (RICAPPS), Spain
i Clinical Pharmacy and Pharmacotherapy Unit, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain
j Pharmalex, Barcelona, Spain
k Pharmacy Service, Hospital Universitario de Puerto Real, Cádiz, Spain
l Medication Area, Catalan Health Service (CatSalut), Barcelona, Spain
m Department of Economics, Carlos III University, Madrid, Spain
n Pharmacy Service, Clínica Universidad de Navarra, Pamplona, Spain
o Barcelona School of Management, Pompeu Fabra University, Barcelona, Spain
Ver más
